Bio-IT World May 26, 2020
Rob Lalonde

Few disciplines have seen more rapid adoption of cloud computing than life sciences research. Datasets are easily anonymized; pipelines are generally comprised of cloud-friendly open-source tools, and data are often shared, making the cloud a convenient meeting point. Overshadowing all of these reasons, however, is an insatiable demand for computing power.

The recent COVID-19 pandemic has shone a bright light on this challenge. In February of 2020, teams from the University of Tennessee and ORNL published a paper on Repurposing Therapeutics for COVID-19. Because SARS-CoV-2 had recently been sequenced, researchers had a working model of the virus. Although complicated to execute, their idea was pretty simple. Why not run computer simulations to find compounds that inhibit the virus interacting with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Cloud, Health IT, Pharma / Biotech, Technology
IBM to expand cloud offering with $6.4bn HashiCorp deal
IBM to acquire HashiCorp in $6.4 billion deal, reports another revenue miss
Oracle Announces World HQ Move to Nashville and Its Autonomous Shield Initiative
Oracle launches Autonomous Shield initiative, with eye on cloud cybersecurity
Enterprises are getting better at detecting security incidents

Share This Article